Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;17(10):e33; author reply e34.
doi: 10.1634/theoncologist.2012-0318.

Trastuzumab and chemotherapy may be appropriate for small, node-negative, HER2-positive breast cancer

Patrick G Morris, Heather L McArthur

Trastuzumab and chemotherapy may be appropriate for small, node-negative, HER2-positive breast cancer

Patrick G Morris et al. Oncologist. 2012.

Abstract

This letter discusses the outcomes of a sequential cohort study of women with T1, N0, HER2-positive breast cancer with trastuzumab.

PubMed Disclaimer

Conflict of interest statement

Disclosures: Heather L. McArthur: GlaxoSmithKline, Bristol-Myers Squibb, Genentech, Roche (H). The other author indicated no financial relationships.

References

    1. Connolly RM, Bardia A. Trastuzumab for small HER-2+ breast cancer: Small tumor, big decision. The Oncologist. 2012;17:508–511. - PMC - PubMed
    1. McArthur HL, Mahoney KM, Morris PG, et al. Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer. Cancer. 2011;117:5461–5468. - PubMed
    1. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Breast Cancer, Version 1.2012. [Accessed June 20, 2012]. Available at http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.

MeSH terms